Relative growth (% Survival) was determined by dividing the CFUs

Relative growth (% Survival) was determined by dividing the CFUs obtained from treated cultures by the

CFUs from cultures without antibiotic. To titrate OMV-mediated protection, OMVs and antimicrobials were co-incubated in 5 mL LB (2 h, 37°C) at the indicated Rigosertib concentrations. The mixture was centrifuged (38,400 g, 1 h), and the supernatant (OMV-pretreated media) transferred to a new tube. Meanwhile, cultures of WT or ETEC E. coli (5 mL) were grown to OD600 0.45, centrifuged (4100 g, 10 min), and the media was removed. The cell pellets were then resuspended to their original culture volume (5 mL) with OMV-pretreated media, incubated (2 h, 200 rpm, 37°C), and see more dilution-plated on LB agar plates (containing kanamycin for WT, not ETEC, cultures) to determine CFU/mL. Relative growth (% Survival) was determined by dividing the CFUs obtained from treated cultures by the CFUs from cultures without antibiotic. Alkaline phosphatase cell integrity assay E. coli MK318 cultures were treated for 2 h with 0.75 μg/mL polymyxin B, or 0.5 μg/mL colistin. A portion of the treated and untreated cultures was dilution-plated for CFU/mL determination. Following the treatment, cells were pelleted (4,100 g, 10 min, 4°C), and the supernatant

was cleared of OMVs (38,400 g, 2 h, 4°C). AP was detected in 150 μL samples of OMV-free RGFP966 datasheet supernatant (S) and the whole cell pellets (WC) using the Anaspec Sensolyte pNPP alkaline phosphatase assay kit per the

manufacturer’s instructions. Anidulafungin (LY303366) Briefly, 50 μl of sample was applied in duplicate to each well of a 96-well plate (Corning), then 50 μl of pNPP substrate solution was added. Absorbance at 405 nm was measured (Fluostar Optima) after 2 h. AP concentrations in samples were derived using a standard curve generated using known concentrations of AP. The ratios of AP in the OMV-free supernatant compared to the whole cells (S/WC) were then normalized to the CFU/mL in the original cultures. Polymyxin B resistance plate assay To assess the time-course of the acquisition of adaptive polymyxin B resistance, the procedure described for the OMV protection assay was used, except that following the indicated treatment of the ETEC cultures with ETEC OMVs and polymyxin B, polymyxin B alone, or LB alone, cultures were streaked on LB agar and LB agar containing 5 μg/ml of polymyxin B with a sterile applicator at 1 h intervals for up to 7 h. T4 titration T4 D+ phage titering was assessed using MK496 as the host strain. Several 10-fold dilutions of a high-concentration lysate were made, 100 μL of each of these dilutions was then combined with 100 μL of MK496 for 5 min, the 200 μL samples were then added to warmed (55°C) top agar (Bactotryptone 13 g/L, NaCl 8 g/L, Na-Citrate-2H2O 2 g/L, Glucose 3 g/L, and Bactoagar 6.

Comments are closed.